– Participated in 'KOREADERMA 2025' held at COEX Magok from October 31 to November 2
Sharing the clinical utility and innovative technologies of 'Density', 'LinearG', and 'Potenza' through offline and online lectures .
– Expected to maximize delivery of Jeisys Philosophy and expand global medical network

Global medical aesthetics specialist company JSIS Medical Co., Ltd. participated in 'KOREADERMA 2025' held at COEX Magok from Friday, October 31 to Sunday, November 2.
KOREADERMA 2025 is Korea's largest international academic conference in the field of skin care, attended by approximately 5,000 dermatologists and global buyers from 65 countries.
Through this conference, JSIS Medical further strengthened its brand value and the trust of medical professionals by delivering a consistent message and user experience. To achieve this, the company planned academic sessions centered on its core product lines, including its flagship radiofrequency (RF) device, "DENSITY," as well as its "LinearZ" and "POTENZA." Lectures based on actual clinical data enhanced product understanding and expanded its global medical network.
During the event, Taiwanese medical experts gave offline lectures, while Korean and Brazilian medical experts also gave presentations on the clinical usefulness and treatment experiences of high-frequency equipment.
Additionally, JSIS Medical showcased its key medical devices and solutions at its exhibition booth, and actively engaged with medical professionals both domestically and internationally, enhancing brand awareness and trust. The 986 people who attended the JSIS Medical booth demonstrated their keen interest in the company's products and technology.
A representative of JSIS Medical said, “KOREADERMA 2025 was a meaningful opportunity for us to officially announce our excellence based on technological prowess and clinical data as a leading company in the global medical aesthetics market,” adding, “We are pleased to be able to further strengthen exchanges with medical professionals at home and abroad and solidify our global brand position through lectures focusing on our representative equipment and conveying our brand philosophy.”
Meanwhile, JSIS Medical continues to invest in research and development (R&D) and pursue technological innovation based on its diverse portfolio of medical devices, including radiofrequency (RF) and high-intensity focused ultrasound (HIFU), and is expanding its brand value in countries around the world, focusing on key equipment such as Density, LinearG, and Potenza.
You must be logged in to post a comment.